Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia
- PMID: 24589695
- DOI: 10.1161/CIRCULATIONAHA.113.001292
Lomitapide and mipomersen: two first-in-class drugs for reducing low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia
Keywords: anticholesteremic agents; cholesterol; hyperlipoproteinemia type 2; lipoproteins, LDL.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical